H
HPC
vs
S
S&P/ASX 300
Over the past 12 months, HPC has underperformed S&P/ASX 300, delivering a return of -71% compared to the S&P/ASX 300's +7% growth.
Stocks Performance
HPC vs S&P/ASX 300
Performance Gap
HPC vs S&P/ASX 300
Performance By Year
HPC vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Hydration Pharmaceuticals Co Ltd
Glance View
The Hydration Pharmaceuticals Co. Ltd. markets and sells a range of liquid, tablet and powder healthy hydration solutions products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-12-14. The firm markets and sells a range of liquid, tablet, and powder Hydration solutions products in North American markets of Canada and the United States, under the Hydralyte brand. The company operates in three segments of the healthy hydration solutions market, consisting of over the counter (OTC) consumer healthcare market, functional beverages market, and vitamin and mineral supplements (VMS) market. Digestive health and paediatric diarrhoea remedies is contained within the OTC Consumer Healthcare market. The Oral Rehydration Solutions market and Functional Beverages market is focused on providing oral rehydration solutions to help replenish important salts and fluids lost. Health and wellness hydration solutions consist in the Vitamin and Mineral Supplements (VMS) market. The VMS market segment offers rehydration with vitamins and minerals in a liquid format.